Form 4: Fortress Biotech CFO David Jin Receives 1 Million Restricted Stock Units

David Jin, CFO of Fortress Biotech, was granted 1,000,000 restricted stock units on December 19, 2024, according to a recent SEC filing.

Summary

• On December 19, 2024, David Jin, the Chief Financial Officer of Fortress Biotech, Inc., was granted 1,000,000 restricted stock units.
• These restricted stock units will vest in 16 equal quarterly installments starting after December 20, 2024.
• The shares underlying these units will be settled in the form of Fortress Biotech's common stock.
• Settlement will occur on the earlier of the tenth business day of January following certain terminations of service or the consummation of a Corporate Transaction as defined in the company's 2013 Stock Incentive Plan.
• Following the transaction, Jin beneficially owns 1,240,893 shares, including 1,230,000 shares underlying deferred restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of restricted stock units is a standard practice and aligns the CFO's interests with shareholders. It doesn't indicate any immediate positive or negative impact but suggests a commitment to long-term value creation.

Positives

• The grant of restricted stock units aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Future Outlook

The restricted stock units will vest over time, subject to the terms of the Fortress Biotech, Inc. 2013 Stock Incentive Plan.

Industry Context

Granting stock options and restricted stock units to key executives is a common practice in the biotech industry to incentivize performance and retain talent.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded biotech companies.
• The size of the grant is relative to the company's market capitalization and the executive's role.
• Comparable companies such as Amgen, Gilead, and Biogen also utilize stock options and restricted stock units as part of their executive compensation packages.

Stakeholder Impact

• Shareholders: The grant aligns management's interests with shareholder value.
• Employees: The grant could boost morale by demonstrating the company's commitment to its executives.

Key Dates